- Research works
- 1 fractional, all time
- Citations
- 8 8.9 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 7% world 28%
Not ranked overall: Taro Pharmaceuticals (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Taro Pharmaceuticals (Canada) publish most on?
By volume in 2022–2025: Phytoestrogen effects and research, Andrographolide Research and Applications and Nanoparticle-Based Drug Delivery.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Phytoestrogen effects and research Pathology and Forensic Medicine 0 works
- 2 Andrographolide Research and Applications Complementary and alternative medicine 0 works
- 3 Nanoparticle-Based Drug Delivery Biomaterials 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Brampton
- Brampton Civic Hospital
- William Osler Health System
- Minnow Environmental (Canada)
- Medtronic (Canada)
- Savaria (Canada)
- EXP (Canada)
- East Wellington Family Health Team
- Loblaw Companies (Canada)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.